Pfizer admits COVID vaccinated persons face high risks of ‘untimely’ death

Pfizer has admitted that there are dangers and high risks which could lead to untimely deaths from the adverse effects of COVID-19 vaccines being imposed on citizens by governments across the world. Pfizer, therefore, invented Blockbuster drug, Eliquis, to counter sudden deaths arising from heart conditions, including those caused by COVID vaccines. Pfizer are subtly creating fresh tension that those who got the vaccine jabs may be close to death, warning that there is “no time to wait” to save their lives from untimely death

Pfizer in collaboration with Bristol Myers Squibb, therefore, intensified the “No Time to Wait” advertisement campaign, mandating people who have symptoms of heart ailments to consult their doctors. They are aggressively marketing Eliquis for the very heart conditions associated with people who received Pfizer’s COVID vaccine.

Pfizer and Bristol Myers Squibb (BMS) have desperately spent $1.28 million on Television advertisement on their ‘No Time To Wait’ campaign in February.

The two pharmaceutical companies have cautioned that people developing symptoms of palpitations and shortness of breath could be facing increased risk of developing atrial fibrillation (AF), deep vein thrombosis (DVT), as well as other types of blood clots and strokes, the same types of cardiovascular ailments found among people who have received COVID-19 vaccines.

Pfizer and Bristol Myers Squibb (BMS) strongly warned victims of covid vaccine adverse effects to seek early medical attention in order to reduce the risk of the serious complications. They stipulated that “Early medical attention” could include prescription drugs, including Eliquis, developed and marketed mainly by Pfizer and BMS.

Industry publication Fierce Pharma had declared: “The aim is to get patients back into their doctors’ offices — and of course, if needed, be diagnosed with any relevant condition that may require them to take a blood thinner, such as Eliquis.”

It was noted that Eliquis, described as a “blockbuster blood thinner and atrial fibrillation (AF) drug,” is a major revenue generator for the Pfizer-BMS alliance, delivering more than $9 billion in annual revenue, far more than competing drugs such as Xarelto (produced by Bayer in conjunction with Johnson & Johnson), and Pradaxa, produced by Boehringer Ingelheim.

There are suspicions and skepticisms that Pfizer may be in the guile of developing new business as the covid vaccines are becoming unpopular following the demystification of coronavirus, itself, across Europe and America. In any case, they have validated reports of adverse effects of covid vaccine across the many countries of the world, including the recent reports of people falling and dying instantly in sporting fields, boardrooms, conference halls, and other public activities venues.

Pfizer and BMS may, therefore, be in a race of redeeming the hazards they cause in developing covid vaccines that failed to make a positive impact in the control of covid but resulted in deadly adverse effects. The  “No Time to Wait” advertisement is given impetus in collaboration with several advocacy organizations and medical societies, including World Thrombosis Day providing assistance for the Pfizer-BMS partnership under the guise of “educating” the public.